Physician Assistant Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Kathleen Smith

Physician Assistant, Medical Somerset, PA Physician Assistant

NPI 1952483695 CMS profile 11253163

329 S Pleasant Avenue, Somerset, PA 15501

Open in the dashboard

General payments

$191

4 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Kathleen Smith of Somerset, PA is reported in the CMS Open Payments database as having received $191 across 4 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 36th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $55 1
2022 General $117 2
2021 General $19 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kathleen Smith
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Kathleen Smith were reported at $0. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Kathleen Smith Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $19 $156 $41–$563 $132
2022 $117 $185 $55–$649 $149
2023 $0 $199 $58–$717 $160
2024 $55 $206 $62–$740 $164
2025 $0 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Boston Scientific Corporation $117 2 payments
  2. Inari Medical, Inc. $55 1 payment
  3. Amarin Pharma Inc. $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Food and Beverage $191 4 payments
Products named General payments · program years 2021–2024
  1. WATCHMAN Access System $117 2 payments
  2. FLOWTRIEVER CATHETER, S $55 1 payment
  3. CT THROMBECTOMY SYSTEM KIT $55 1 payment
  4. Vascepa $19 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 106 drugs

Part D claims

5,499

Median for Physician Assistant: 241

Drug cost

$654,470

Median for Physician Assistant: $4,110

Branded share of claims

24.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Jardiance Empagliflozin Brand 147 $142,031
Trulicity Dulaglutide Brand 96 $114,845
Ozempic Semaglutide Brand 75 $64,089
Eliquis Apixaban Brand 89 $60,260
Mounjaro Tirzepatide Brand 56 $54,654
Prolia Denosumab Brand 20 $33,814
Tradjenta Linagliptin Brand 31 $26,371
Linzess Linaclotide Brand 27 $19,248
Myrbetriq Mirabegron Brand 26 $14,150
Spiriva Respimat Tiotropium Bromide Brand 24 $13,509

The 10 drugs with the highest cost, of 106 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$22,789

Of which drugs: $1,720

Medicare patients

114

Average age 72

Services billed

580

82 women, 32 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 68%
Arthritis 48%
Depression 26%
Diabetes 25%
Osteoporosis 23%
Chronic kidney disease 18%
COPD 18%
Ischemic heart disease 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Influenza vaccine, trivalent derived from recombinant dna 90673 Office 11 11 $539

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

4 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record